Pharmacist - Physician Collaborative Approach to the Management of Metabolic Syndrome
1 other identifier
interventional
199
1 country
1
Brief Summary
This study devised an experimental focused pharmaceutical care program, allowed a clinical pharmacist to work in a physician office to assess and manage patients' metabolic syndrome status and its individual components. This study described the clinical benefits of physician- clinical pharmacist interaction in achieving improved glycemic control, lipid and blood pressure measurements, involving medication, diet, physical activity and patient heath care counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 5, 2010
CompletedFirst Posted
Study publicly available on registry
April 6, 2010
CompletedApril 6, 2010
March 1, 2009
8 months
April 5, 2010
April 5, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Improvements in metabolic syndrome status over the course of this study and absolute mean improvements in individual MS components.
Primary outcomes were specified as: * Fasting blood glucose \< 110 mg/dl. * Body weight BMI \< 25 kg/m2. * Waist circumference ≤ 102 cm (40 in) in men and ≤ 88 cm (35 inches) in women. * Serum triglycerides \< 150 mg/dl. * HDL cholesterol ≥40mg/dl in men and ≥50mg/dl in women. * Blood pressure \< 130/85 mm Hg or \< 130/80 mm Hg when patients were diabetic.
6 monthS
Study Arms (2)
intervention
ACTIVE COMPARATORpharmacist-physician collaborative approach to manage Metabolic syndrome
control
NO INTERVENTIONphysician only team to manage Metabolic syndrome
Interventions
Patients' metabolic components were assessed and managed collaboratively by focused care plan designed by the clinical pharmacist and approved by the physician.Pharmacist emphasized the change in lifestyle, particularly weight loss and physical activity as a first line therapy for at least 3 months, patients were started on drug therapy when needed as recommended by clinical guidelines.
Eligibility Criteria
You may qualify if:
- Meeting at least 3 of the 5 criteria for the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATPIII) for the diagnosis of Metabolic syndrome upon the time of enrollment. :
- Abdominal circumference \>102 cm in males or \>88 cm in females.
- HDL cholesterol \< 40 mg/dl for males or \< 50 mg/dl for females.
- Triglycerides ≥ 150 mg/dl.
- Blood pressure ≥ 130/85 mmHg or receiving hypertension treatment.
- Baseline glycemia ≥ 110 mg/dl.
You may not qualify if:
- Patients with hypertensive urgency or emergency with BP more than (180/110).
- Patients with recent stroke or myocardial infraction (within past 6 months).
- Patients with Class III or IV Chronic heart Failure (CHF).
- Patients with Unstable angina.
- Patients with Serious renal or hepatic disease.
- Pregnant patients.
- Patients with Dementia or cognitive impairment.
- If the patient is unable to provide informed written consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
family medicine clinic JUH
Amman, Amman Governorate, 13046, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eman Hammad, MSc
University of Jordan/ Faculty of Pharmacy
- STUDY DIRECTOR
Abla Al bsoul, PhD
University of Jordan/ Faculty of Pharmacy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 5, 2010
First Posted
April 6, 2010
Study Start
March 1, 2009
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
April 6, 2010
Record last verified: 2009-03